Showing results (761-770 of 1,005) with videos related to

Sort By:
Pageof 101
Regenerative Therapy|December 7, 2022
Orally administrable peptides derived from egg yolk promote skeletal repair and ameliorate degenerative skeletal disorders in mouse modelsYoshiaki Kitaura, Utano Nakamura, Chihiro Awada, et al.
British Journal of Cancer|April 3, 1999
Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus scheduleA Awada, C J Punt, M J Piccart, et al.
The Journal of Obstetrics and Gynaecology Research|November 26, 2019
Risk score for failed trial of vaginal birth after a previous cesarean section including data of labor courseLuis C Machado Junior, Eduardo A B Famá, Jorge W Zamboni, et al.
Anti-Cancer Drugs|August 1, 1994
Phase I and pharmacokinetic studies of topotecan administered as a 72 or 120 h continuous infusionH A Burris, A Awada, J G Kuhn, et al.
Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit|October 16, 2019
Management of patients with metastatic colorectal cancer in Lebanese hospitals and associated direct cost: a multicentre cohort studyAnna Maria Henaine, Georges Chahine, Marcel Massoud, et al.
The Oncologist|May 2, 2007
Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumorsDirk Strumberg, Jeffrey W Clark, Ahmad Awada, et al.
ESMO Open|December 20, 2021
Current landscape of ESMO/ASCO Global Curriculum adoption and medical oncology recognition: a global surveyT Cufer, M Kosty, P Osterlund, et al.
European Journal of Cancer (Oxford, England : 1990)|January 21, 2016
p53 Reactivation by PRIMA-1(Met) (APR-246) sensitises (V600E/K)BRAF melanoma to vemurafenibMohammad Krayem, Fabrice Journe, Murielle Wiedig, et al.
European Journal of Cancer (Oxford, England : 1990)|November 28, 2007
The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: results of a phase I study with pharmacokineticsAhmad Awada, Fatima Cardoso, Christel Fontaine, et al.
ESMO Open|December 1, 2022
Antitumor activity of lurbinectedin in combination with oral capecitabine in patients with metastatic breast cancerA H Awada, V Boni, V Moreno, et al.
Pageof 101